Info
Description
HEPTA Medical is developing an endoscopically-delivered ablation catheter that uses microwave together with temperature-based feedback and real-time dosing to precisely target and ablate pulmonary nodules – the precursor of lung cancer- without the need for surgery or radiation. The HEPTA Med device aims to overcome the significant limiting factors of therapeutic management strategies under development for pulmonary nodules, with various players in the field attempting to find titration and/or verification solutions to enable routine adoption by clinicians : the lack of clinically meaningful feedback to confirm success in therapy and operational safety.
HEPTA Medical is led by a team of serial medtech entrepreneurs experienced in product development, validation and launch.